Century Health raises $5M to turn clinic data into real-world evidence with AI
What's the deal? Century Health, an AI-enabled real-world evidence platform, has raised $5M in an oversubscribed seed round led by Origin Ventures. InnovateHealth Ventures, 25madison, Next Play Ventures, 2048 Ventures, Alumni Ventures, and strategic angels also participated.
The startup builds clinical data infrastructure for life sciences companies, partnering with specialty practices across the US to generate real-world evidence on drug effectiveness and comparative treatments.
Century Health plans to use the funds to scale its data network, expand disease-specific capabilities, and deepen collaborations with life sciences companies.
Why now? Life sciences companies, frontier AI labs, and researchers all want better access to accurate clinical data — and most of it sits locked inside EHR systems at private practices. Century Health's platform, called CHARM (Century Health Abstraction & Retrieval Model), ingests EHR records to create research-ready datasets and recently hit 97% accuracy in clinical data abstraction compared with human experts.
"What's happening in the community settings, in private practices is incredibly important to understanding which drugs work," said cofounder and chief executive officer Vish Srivastava.
The company focuses on chronic conditions outside oncology — a space cofounder and chief technology officer Sanjay Hariharan says is underserved. "Clinical data is particularly meaningful and something that no one really has access to, besides us," he said.
What could go wrong? Clinical data extraction from fragmented EHR systems is notoriously difficult, and maintaining high accuracy at scale will be a challenge. Century Health also needs to convince private practices to share sensitive patient data — a process that requires trust, compliance, and time. Competition from larger data players in the real-world evidence space could intensify as AI makes clinical data more accessible.
The signal: The round reflects growing investor appetite for AI infrastructure that sits between healthcare providers and life sciences R&D. As drug developers increasingly rely on real-world evidence for everything from clinical trial design to post-market surveillance, companies that can turn messy clinical records into structured, high-fidelity datasets stand to capture significant value.
"When we look back and think about the inputs necessary to drive medical breakthroughs, the most important thing is data," said Prashant Shukla, partner at Origin Ventures. The firm sees Century Health building a proprietary data asset that can support drug discovery, R&D, and safety and efficacy analysis — with a high-margin revenue model selling to life sciences and AI ecosystem buyers.
Read more: mobihealthnews.com
